Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 192 of 196 entries
Sorted by: Best Match Show Resources per page
The role of cDC1s .

F1000Research

Theisen D, Murphy K.
PMID: 28184299
F1000Res. 2017 Feb 01;6:98. doi: 10.12688/f1000research.9997.1. eCollection 2017.

The cDC1 subset of classical dendritic cells is specialized for priming CD8 T cell responses through the process of cross-presentation. The molecular mechanisms of cross-presentation remain incompletely understood because of limited biochemical analysis of rare cDC1 cells, difficulty in...

Cite
Theisen D, Murphy K. The role of cDC1s . F1000Res. 2017;6:98doi: 10.12688/f1000research.9997.1.
Theisen, D., & Murphy, K. (2017). The role of cDC1s . F1000Research, 698. https://doi.org/10.12688/f1000research.9997.1
Theisen, Derek, and Murphy, Kenneth. "The role of cDC1s ." F1000Research vol. 6 (2017): 98. doi: https://doi.org/10.12688/f1000research.9997.1
Theisen D, Murphy K. The role of cDC1s . F1000Res. 2017 Feb 01;6:98. doi: 10.12688/f1000research.9997.1. eCollection 2017. PMID: 28184299; PMCID: PMC5288679.
Copy Download .nbib Format: NLM
The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer.

Advances in urology

Correa AF, Theisen K, Ferroni M, Maranchie JK, Hrebinko R, Davies BJ, Gingrich JR.
PMID: 26550012
Adv Urol. 2015;2015:656918. doi: 10.1155/2015/656918. Epub 2015 Oct 13.

Background. Thirty to forty percent of patients with high grade nonmuscle invasive bladder cancer (NMIBC) fail to respond to intravesical therapy with bacillus Calmette-Guerin (BCG). Interferon-α2B plus BCG has been shown to be effective in a subset of patients...

Cite
Correa AF, Theisen K, Ferroni M, et al. The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer. Adv Urol. 2015;2015:656918doi: 10.1155/2015/656918.
Correa, A. F., Theisen, K., Ferroni, M., Maranchie, J. K., Hrebinko, R., Davies, B. J., & Gingrich, J. R. (2015). The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer. Advances in urology, 2015656918. https://doi.org/10.1155/2015/656918
Correa, Andres F, et al. "The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer." Advances in urology vol. 2015 (2015): 656918. doi: https://doi.org/10.1155/2015/656918
Correa AF, Theisen K, Ferroni M, Maranchie JK, Hrebinko R, Davies BJ, Gingrich JR. The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer. Adv Urol. 2015;2015:656918. doi: 10.1155/2015/656918. Epub 2015 Oct 13. PMID: 26550012; PMCID: PMC4621325.
Copy Download .nbib Format: NLM
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia.

Cell reports

An D, Schneller JL, Frassetto A, Liang S, Zhu X, Park JS, Theisen M, Hong SJ, Zhou J, Rajendran R, Levy B, Howell R, Besin G, Presnyak V, Sabnis S, Murphy-Benenato KE, Kumarasinghe ES, Salerno T, Mihai C, Lukacs CM, Chandler RJ, Guey LT, Venditti CP, Martini PGV.
PMID: 30157442
Cell Rep. 2018 Aug 28;24(9):2520. doi: 10.1016/j.celrep.2018.08.049.

No abstract available.

Cite
An D, Schneller JL, Frassetto A, et al. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia. Cell Rep. 2018;24(9):2520doi: 10.1016/j.celrep.2018.08.049.
An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J. S., Theisen, M., Hong, S. J., Zhou, J., Rajendran, R., Levy, B., Howell, R., Besin, G., Presnyak, V., Sabnis, S., Murphy-Benenato, K. E., Kumarasinghe, E. S., Salerno, T., Mihai, C., Lukacs, C. M., Chandler, R. J., Guey, L. T., Venditti, C. P., & Martini, P. G. V. (2018). Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia. Cell reports, 24(9), 2520. https://doi.org/10.1016/j.celrep.2018.08.049
An, Ding, et al. "Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia." Cell reports vol. 24,9 (2018): 2520. doi: https://doi.org/10.1016/j.celrep.2018.08.049
An D, Schneller JL, Frassetto A, Liang S, Zhu X, Park JS, Theisen M, Hong SJ, Zhou J, Rajendran R, Levy B, Howell R, Besin G, Presnyak V, Sabnis S, Murphy-Benenato KE, Kumarasinghe ES, Salerno T, Mihai C, Lukacs CM, Chandler RJ, Guey LT, Venditti CP, Martini PGV. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia. Cell Rep. 2018 Aug 28;24(9):2520. doi: 10.1016/j.celrep.2018.08.049. PMID: 30157442.
Copy Download .nbib Format: NLM
[No title available]

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Benestad EEP, Olsen GF, Thesen J, Aars H, Bjørkman M.
PMID: 29411566
Tidsskr Nor Laegeforen. 2018 Feb 05;138(3). doi: 10.4045/tidsskr.18.0070. Print 2018 Feb 06.

No abstract available.

Cite
Benestad EEP, Olsen GF, Thesen J, et al. Hjelp der den enkelte befinner seg. . Tidsskr Nor Laegeforen. 2018;138(3)doi: 10.4045/tidsskr.18.0070.
Benestad, E. E. P., Olsen, G. F., Thesen, J., Aars, H., & Bjørkman, M. (2018). Hjelp der den enkelte befinner seg. . Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 138(3), . https://doi.org/10.4045/tidsskr.18.0070
Benestad, Esben Esther P, et al. "Hjelp der den enkelte befinner seg." . Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 138,3 (2018). doi: https://doi.org/10.4045/tidsskr.18.0070
Benestad EEP, Olsen GF, Thesen J, Aars H, Bjørkman M. Hjelp der den enkelte befinner seg. . Tidsskr Nor Laegeforen. 2018 Feb 05;138(3). doi: 10.4045/tidsskr.18.0070. Print 2018 Feb 06. Norwegian. PMID: 29411566.
Copy Download .nbib Format: NLM
Finite element model of a below-knee amputation: a feasibility study.

Computer methods in biomechanics and biomedical engineering

Campion D, Dakhil N, Llari M, Evin M, Mo F, Thefenne L, Behr M.
PMID: 29088638
Comput Methods Biomech Biomed Engin. 2017 Oct;20:35-36. doi: 10.1080/10255842.2017.1382848.

No abstract available.

Cite
Campion D, Dakhil N, Llari M, et al. Finite element model of a below-knee amputation: a feasibility study. Comput Methods Biomech Biomed Engin. 2017;20:35-36doi: 10.1080/10255842.2017.1382848.
Campion, D., Dakhil, N., Llari, M., Evin, M., Mo, F., Thefenne, L., & Behr, M. (2017). Finite element model of a below-knee amputation: a feasibility study. Computer methods in biomechanics and biomedical engineering, 2035-36. https://doi.org/10.1080/10255842.2017.1382848
Campion, D, et al. "Finite element model of a below-knee amputation: a feasibility study." Computer methods in biomechanics and biomedical engineering vol. 20 (2017): 35-36. doi: https://doi.org/10.1080/10255842.2017.1382848
Campion D, Dakhil N, Llari M, Evin M, Mo F, Thefenne L, Behr M. Finite element model of a below-knee amputation: a feasibility study. Comput Methods Biomech Biomed Engin. 2017 Oct;20:35-36. doi: 10.1080/10255842.2017.1382848. PMID: 29088638.
Copy Download .nbib Format: NLM
Human motor control of landing from a drop in simulated microgravity.

Journal of applied physiology (Bethesda, Md. : 1985)

Gambelli CN, Theisen D, Willems PA, Schepens B.
PMID: 27516535
J Appl Physiol (1985). 2016 Sep 01;121(3):760-770. doi: 10.1152/japplphysiol.00305.2016. Epub 2016 Aug 11.

Landing on the ground on one's feet implies that the energy gained during the fall be dissipated. The aim of this study is to assess human motor control of landing in different conditions of fall initiation, simulated gravity, and...

Cite
Gambelli CN, Theisen D, Willems PA, et al. Human motor control of landing from a drop in simulated microgravity. J Appl Physiol (1985). 2016;121(3):760-770doi: 10.1152/japplphysiol.00305.2016.
Gambelli, C. N., Theisen, D., Willems, P. A., & Schepens, B. (2016). Human motor control of landing from a drop in simulated microgravity. Journal of applied physiology (Bethesda, Md. : 1985), 121(3), 760-770. https://doi.org/10.1152/japplphysiol.00305.2016
Gambelli, C N, et al. "Human motor control of landing from a drop in simulated microgravity." Journal of applied physiology (Bethesda, Md. : 1985) vol. 121,3 (2016): 760-770. doi: https://doi.org/10.1152/japplphysiol.00305.2016
Gambelli CN, Theisen D, Willems PA, Schepens B. Human motor control of landing from a drop in simulated microgravity. J Appl Physiol (1985). 2016 Sep 01;121(3):760-770. doi: 10.1152/japplphysiol.00305.2016. Epub 2016 Aug 11. PMID: 27516535.
Copy Download .nbib Format: NLM
Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample.

Alzheimer's & dementia (Amsterdam, Netherlands)

Eckerström M, Göthlin M, Rolstad S, Hessen E, Eckerström C, Nordlund A, Johansson B, Svensson J, Jonsson M, Sacuiu S, Wallin A.
PMID: 28560310
Alzheimers Dement (Amst). 2017 May 16;8:96-107. doi: 10.1016/j.dadm.2017.04.006. eCollection 2017.

INTRODUCTION: Subjective cognitive decline (SCD) and biomarker-based "at-risk" concepts such as "preclinical" Alzheimer's disease (AD) have been developed to predict AD dementia before objective cognitive impairment is detectable. We longitudinally evaluated cognitive outcome when using these classifications.METHODS: Memory clinic...

Cite
Eckerström M, Göthlin M, Rolstad S, et al. Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample. Alzheimers Dement (Amst). 2017;8:96-107doi: 10.1016/j.dadm.2017.04.006.
Eckerström, M., Göthlin, M., Rolstad, S., Hessen, E., Eckerström, C., Nordlund, A., Johansson, B., Svensson, J., Jonsson, M., Sacuiu, S., & Wallin, A. (2017). Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample. Alzheimer's & dementia (Amsterdam, Netherlands), 896-107. https://doi.org/10.1016/j.dadm.2017.04.006
Eckerström, Marie, et al. "Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 8 (2017): 96-107. doi: https://doi.org/10.1016/j.dadm.2017.04.006
Eckerström M, Göthlin M, Rolstad S, Hessen E, Eckerström C, Nordlund A, Johansson B, Svensson J, Jonsson M, Sacuiu S, Wallin A. Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample. Alzheimers Dement (Amst). 2017 May 16;8:96-107. doi: 10.1016/j.dadm.2017.04.006. eCollection 2017. PMID: 28560310; PMCID: PMC5443895.
Copy Download .nbib Format: NLM
Trans people are being let down by the Health Service.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Benestad EEP, Thesen J, Aars H, Olsen GF, Bjørkman M.
PMID: 29135196
Tidsskr Nor Laegeforen. 2017 Nov 13;137(21). doi: 10.4045/tidsskr.17.0422. Print 2017 Nov 14.

No abstract available.

Cite
Benestad EEP, Thesen J, Aars H, et al. Helsevesenet svikter transpersoner. Trans people are being let down by the Health Service. Tidsskr Nor Laegeforen. 2017;137(21)doi: 10.4045/tidsskr.17.0422.
Benestad, E. E. P., Thesen, J., Aars, H., Olsen, G. F., & Bjørkman, M. (2017). Helsevesenet svikter transpersoner. Trans people are being let down by the Health Service. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 137(21), . https://doi.org/10.4045/tidsskr.17.0422
Benestad, Esben Esther P, et al. "Helsevesenet svikter transpersoner." Trans people are being let down by the Health Service. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 137,21 (2017). doi: https://doi.org/10.4045/tidsskr.17.0422
Benestad EEP, Thesen J, Aars H, Olsen GF, Bjørkman M. Helsevesenet svikter transpersoner. Trans people are being let down by the Health Service. Tidsskr Nor Laegeforen. 2017 Nov 13;137(21). doi: 10.4045/tidsskr.17.0422. Print 2017 Nov 14. Norwegian. PMID: 29135196.
Copy Download .nbib Format: NLM
No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades.

British journal of haematology

Chalopin T, Vallet N, Theisen O, Ochmann M, Tiab M, Godmer P, Barin C, Hérault O, Gyan E, Le Gouill S, Avet-Loiseau H, Benboubker L, Moreau P, Touzeau C.
PMID: 33928635
Br J Haematol. 2021 Aug;194(3):635-638. doi: 10.1111/bjh.17488. Epub 2021 Apr 29.

No abstract available.

Cite
Chalopin T, Vallet N, Theisen O, et al. No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades. Br J Haematol. 2021;194(3):635-638doi: 10.1111/bjh.17488.
Chalopin, T., Vallet, N., Theisen, O., Ochmann, M., Tiab, M., Godmer, P., Barin, C., Hérault, O., Gyan, E., Le Gouill, S., Avet-Loiseau, H., Benboubker, L., Moreau, P., & Touzeau, C. (2021). No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades. British journal of haematology, 194(3), 635-638. https://doi.org/10.1111/bjh.17488
Chalopin, Thomas, et al. "No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades." British journal of haematology vol. 194,3 (2021): 635-638. doi: https://doi.org/10.1111/bjh.17488
Chalopin T, Vallet N, Theisen O, Ochmann M, Tiab M, Godmer P, Barin C, Hérault O, Gyan E, Le Gouill S, Avet-Loiseau H, Benboubker L, Moreau P, Touzeau C. No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades. Br J Haematol. 2021 Aug;194(3):635-638. doi: 10.1111/bjh.17488. Epub 2021 Apr 29. PMID: 33928635.
Copy Download .nbib Format: NLM
The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma.

Oncogene

Boone MA, Taslim C, Crow JC, Selich-Anderson J, Byrum AK, Showpnil IA, Sunkel BD, Wang M, Stanton BZ, Theisen ER, Lessnick SL.
PMID: 34145397
Oncogene. 2021 Jul;40(29):4759-4769. doi: 10.1038/s41388-021-01876-5. Epub 2021 Jun 18.

Ewing sarcoma is an aggressive bone cancer of children and young adults defined by the presence of a chromosomal translocation: t(11;22)(q24;q12). The encoded protein, EWS/FLI, fuses the amino-terminal domain of EWS to the carboxyl-terminus of FLI. The EWS portion...

Cite
Boone MA, Taslim C, Crow JC, et al. The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma. Oncogene. 2021;40(29):4759-4769doi: 10.1038/s41388-021-01876-5.
Boone, M. A., Taslim, C., Crow, J. C., Selich-Anderson, J., Byrum, A. K., Showpnil, I. A., Sunkel, B. D., Wang, M., Stanton, B. Z., Theisen, E. R., & Lessnick, S. L. (2021). The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma. Oncogene, 40(29), 4759-4769. https://doi.org/10.1038/s41388-021-01876-5
Boone, Megann A, et al. "The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma." Oncogene vol. 40,29 (2021): 4759-4769. doi: https://doi.org/10.1038/s41388-021-01876-5
Boone MA, Taslim C, Crow JC, Selich-Anderson J, Byrum AK, Showpnil IA, Sunkel BD, Wang M, Stanton BZ, Theisen ER, Lessnick SL. The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma. Oncogene. 2021 Jul;40(29):4759-4769. doi: 10.1038/s41388-021-01876-5. Epub 2021 Jun 18. PMID: 34145397; PMCID: PMC8298202.
Copy Download .nbib Format: NLM
Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein.

Epigenetics

Theisen ER, Selich-Anderson J, Miller KR, Tanner JM, Taslim C, Pishas KI, Sharma S, Lessnick SL.
PMID: 32842875
Epigenetics. 2021 Apr;16(4):405-424. doi: 10.1080/15592294.2020.1805678. Epub 2020 Aug 25.

Paediatric cancers commonly harbour quiet mutational landscapes and are instead characterized by single driver events such as the mutation of critical chromatin regulators, expression of oncohistones, or expression of oncogenic fusion proteins. These events ultimately promote malignancy through disruption...

Cite
Theisen ER, Selich-Anderson J, Miller KR, et al. Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics. 2020;16(4):405-424doi: 10.1080/15592294.2020.1805678.
Theisen, E. R., Selich-Anderson, J., Miller, K. R., Tanner, J. M., Taslim, C., Pishas, K. I., Sharma, S., & Lessnick, S. L. (2021). Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics, 16(4), 405-424. https://doi.org/10.1080/15592294.2020.1805678
Theisen, Emily R, et al. "Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein." Epigenetics vol. 16,4 (2021): 405-424. doi: https://doi.org/10.1080/15592294.2020.1805678
Theisen ER, Selich-Anderson J, Miller KR, Tanner JM, Taslim C, Pishas KI, Sharma S, Lessnick SL. Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics. 2021 Apr;16(4):405-424. doi: 10.1080/15592294.2020.1805678. Epub 2020 Aug 25. PMID: 32842875; PMCID: PMC7993145.
Copy Download .nbib Format: NLM
Discrimination of deletion to point cytokine mutants based on an array of cross-reactive receptors mimicking protein recognition by heparan sulfate.

Analytical and bioanalytical chemistry

Genua M, Garçon LA, Sergeeva YN, Saesen E, Musnier B, Buhot A, Billon M, Gout E, Sadir R, Lortat-Jacob H, Le Narvor C, Bonnaffé D, Livache T, Hou Y.
PMID: 34258651
Anal Bioanal Chem. 2022 Jan;414(1):551-559. doi: 10.1007/s00216-021-03516-z. Epub 2021 Jul 13.

Differential sensing of proteins based on cross-reactive arrays and pattern recognition is a promising technique for the detection and identification of proteins. In this study, a rational biomimetic strategy has been used to prepare sensing materials capable of discriminating...

Cite
Genua M, Garçon LA, Sergeeva YN, et al. Discrimination of deletion to point cytokine mutants based on an array of cross-reactive receptors mimicking protein recognition by heparan sulfate. Anal Bioanal Chem. 2021;414(1):551-559doi: 10.1007/s00216-021-03516-z.
Genua, M., Garçon, L. A., Sergeeva, Y. N., Saesen, E., Musnier, B., Buhot, A., Billon, M., Gout, E., Sadir, R., Lortat-Jacob, H., Le Narvor, C., Bonnaffé, D., Livache, T., & Hou, Y. (2022). Discrimination of deletion to point cytokine mutants based on an array of cross-reactive receptors mimicking protein recognition by heparan sulfate. Analytical and bioanalytical chemistry, 414(1), 551-559. https://doi.org/10.1007/s00216-021-03516-z
Genua, Maria, et al. "Discrimination of deletion to point cytokine mutants based on an array of cross-reactive receptors mimicking protein recognition by heparan sulfate." Analytical and bioanalytical chemistry vol. 414,1 (2022): 551-559. doi: https://doi.org/10.1007/s00216-021-03516-z
Genua M, Garçon LA, Sergeeva YN, Saesen E, Musnier B, Buhot A, Billon M, Gout E, Sadir R, Lortat-Jacob H, Le Narvor C, Bonnaffé D, Livache T, Hou Y. Discrimination of deletion to point cytokine mutants based on an array of cross-reactive receptors mimicking protein recognition by heparan sulfate. Anal Bioanal Chem. 2022 Jan;414(1):551-559. doi: 10.1007/s00216-021-03516-z. Epub 2021 Jul 13. PMID: 34258651.
Copy Download .nbib Format: NLM
Showing 181 to 192 of 196 entries